Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia

References

• Jensen TS, Backonja MM, Hernandez JS, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006;3:108-19
   PubMedGoogle Scholar
• Candrilli SD, Davis KL, Kan HJ, et al. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications 2007;21:306-14
   PubMed Web of Science ®Google Scholar
• Freyhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009;339:391-5
   Google Scholar
• Vinik AI, Park TS, Stansberry KB, et al. Diabetic neuropathies. Diabetologia 2000;43:957-73
   PubMed Web of Science ®Google Scholar
• Sadosky A, McDermott AM, Brandenburg NA, et al. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract 2008;8:45-56
   PubMedGoogle Scholar
• Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 2008;9:660-74
   PubMed Web of Science ®Google Scholar
• Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8
   PubMed Web of Science ®Google Scholar
• Saadi H, Carruthers SG, Nagelkerke N, et al. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. Diabetes Res Clin Pract 2007;78:369-77
   PubMed Web of Science ®Google Scholar
• Al Nozha MM, Al Maatouq MA, Al Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25:1603-10
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
   PubMed Web of Science ®Google Scholar
• Hoffman DL, Sadosky A, Alvir J. Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract 2009;9:35-42
   PubMed Web of Science ®Google Scholar
• Al Mahroos F, Al Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med 2007;27:25-31
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO, 2000. Technical Report Series no. 894
   Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36
   PubMed Web of Science ®Google Scholar
• Akbar DH, Mira SA, Zawawi TH, et al. Subclinical diabetic neuropathy: a common complication in Saudi diabetics. Saudi Med J 2000;21:433-7
   PubMed Web of Science ®Google Scholar
• Nielsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi Arabian patients with type 2 diabetes. Diabetes Res Clin Pract 1998;41:63-9
   PubMed Web of Science ®Google Scholar
• Sulimani RA, Famuyiwa OO, Mekki MO. Pattern of diabetic foot lesions in Saudi Arabia: Experience from King Khalid University Hospital, Riyadh. Ann Saudi Med 1991;11:47-50
   PubMed Web of Science ®Google Scholar
• Al Maskari F, El Sadig zM. Prevalence of risk factors for diabetic foot complications. BMC Fam Pract 2007;8:59
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995;122:561-8
   PubMed Web of Science ®Google Scholar
• Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9
   PubMed Web of Science ®Google Scholar
• Oyibo SO, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002;19:870-3
   PubMed Web of Science ®Google Scholar
• Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94
   PubMed Web of Science ®Google Scholar
• Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006;108:477-81
   PubMed Web of Science ®Google Scholar
• Backonja MM, Krause SJ. Neuropathic pain questionnaire–short form. Clin J Pain 2003;19:315-6
   PubMed Web of Science ®Google Scholar
• Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332-8
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108:248-57
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
   PubMed Web of Science ®Google Scholar
• Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 2005;6:41-4
   PubMed Web of Science ®Google Scholar
• Rejas J, Ribera MV, Ruiz M, et al. Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain 2007;11:329-40
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
   PubMed Web of Science ®Google Scholar
• Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12:13-21
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-69
   PubMed Web of Science ®Google Scholar
• Frank B, Cousins MJ. Pregabalin in the treatment of neuropathic pain associated with diabetic peripheral neuropathy. Future Neurol 2008;3:631-9
   Google Scholar
• Zareba G. Pregabalin: a new agent for the treatment of neuropathic pain. Drugs Today (Barc) 2005;41:509-16
   PubMed Web of Science ®Google Scholar